Fear-Mongering and Stigmatizing Medications is Only Harming You and Your Community

The current trend among the chronic pain community — unfortunately driven by some of their loudest advocates — is to stigmatize medications which can highly effective for many patients and for the right conditions. One of the main targets of this stigmatizing misinformation is buprenorphine. Why? Because buprenorphine is a partial-agonist opioid medication which is frequently used for the treatment of patients with substance use disorder, specifically opioid use disorder, for medication assisted recovery (MAR).